Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis

Abstract

These results implicate increased matriptase expression and activity in the pathogenesis of pulmonary fibrosis in human IPF and in an experimental mouse model. Overall, targeting matriptase, or treatment by CM, which is already in clinical use for other diseases, may represent potential therapies for IPF.